OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 |
US Biomax |
|
266€ |
|
Pub |
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81 |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed |
US Biomax |
|
81€ |
|
Pub |
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296 |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed |
US Biomax |
|
382€ |
|
Pub |
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258 |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 |
BC04002 |
Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- |
US Biomax |
|
296€ |
|
Pub |
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin |
US Biomax |
|
296€ |
|
Pub |
CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
487€ |
|
Pub |
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
OV1003 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185 |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90 |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 |
US Biomax |
|
314€ |
|
Pub |
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394 |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626 |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
KD1001 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed |
US Biomax |
|
114€ |
|
Pub |
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296 |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed |
US Biomax |
|
296€ |
|
Pub |
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
ST1003 |
Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T113 |
Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
UT1001 |
Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores US Biomax 231 |
BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 |
BC03002 |
Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 |
BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 |
BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores |
US Biomax |
|
321€ |
|
Pub |
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores |
US Biomax |
|
321€ |
|
Pub |
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 |
US Biomax |
|
314€ |
|
Pub |
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 |
BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data |
US Biomax |
|
266€ |
|
Pub |
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 |
US Biomax |
|
266€ |
|
Pub |
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 |
US Biomax |
|
456€ |
|
Pub |
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 |
US Biomax |
|
231€ |
|
Pub |
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267 |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 |
CO2081 |
Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626 |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 |
US Biomax |
|
266€ |
|
Pub |
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LV1001 |
Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185 |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 |
US Biomax |
|
88€ |
|
Pub |
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed |
US Biomax |
|
811€ |
|
Pub |
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
MGS801 |
Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231 |
OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 |
US Biomax |
|
231€ |
|
Pub |
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 |
OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 |
US Biomax |
|
456€ |
|
Pub |
OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2085 |
Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2086 |
Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2087 |
Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2088 |
Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2089 |
Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
OV484 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
OV485 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 |
US Biomax |
|
99€ |
|
Pub |
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T111 |
Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90 |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105 |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231 |
BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores |
US Biomax |
|
231€ |
|
Pub |
BC04011 Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed US Biomax 185 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
185€ |
|
Pub |
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 |
US Biomax |
|
231€ |
|
Pub |
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 |
US Biomax |
|
231€ |
|
Pub |
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC11115 |
Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BL1921 |
Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296 |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a |
US Biomax |
|
88€ |
|
Pub |
BR8016 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BR8017 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314 |
CNS801 |
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores |
US Biomax |
|
314€ |
|
Pub |
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 US Biomax 321 |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 |
US Biomax |
|
321€ |
|
Pub |
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
CO1003 |
Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2088 |
Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
CO485 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429 |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi |
US Biomax |
|
429€ |
|
Pub |
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
CR1002 |
Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CR1921 Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
CR1921 |
Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2084 |
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2085 |
Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES1921 Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ES1921 |
Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210 |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278 |
ES8012 |
Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 |
US Biomax |
|
266€ |
|
Pub |
KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
KD1921 |
Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2085 |
Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2087 |
Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2088 |
Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266 |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 |
US Biomax |
|
266€ |
|
Pub |
LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1008 |
Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20810 |
Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20811 |
Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2088 |
Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2089 |
Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231 |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 |
US Biomax |
|
231€ |
|
Pub |
LV1003 Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores US Biomax 314 |
LV1003 |
Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397 |
LV1201 |
Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
397€ |
|
Pub |
LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 |
LV2084 |
Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
516€ |
|
Pub |
LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2085 |
Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2087 |
Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2088 |
Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
LV484 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
LV485 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
LV961 Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed US Biomax 228 |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
228€ |
|
Pub |
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231 |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 |
US Biomax |
|
231€ |
|
Pub |
LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296 |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 |
US Biomax |
|
231€ |
|
Pub |
OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231 |
OV1501 |
Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores |
US Biomax |
|
231€ |
|
Pub |
OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
OV1921 |
Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
OV8010 Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
PA1002 |
Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
PA1003 Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores US Biomax 314 |
PA1003 |
Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
PA1921 Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
PA1921 |
Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456 |
PA2081 |
Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 |
PA961 |
Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores |
US Biomax |
|
278€ |
|
Pub |
PR1001 Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores US Biomax 266 |
PR1001 |
Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314 |
PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 |
US Biomax |
|
314€ |
|
Pub |
RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
RE601 |
Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
ST1002 |
Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
ST1921 Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T013 |
Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T033 |
Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T041 |
Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 |
US Biomax |
|
88€ |
|
Pub |
T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 |
US Biomax |
|
88€ |
|
Pub |
T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b |
US Biomax |
|
88€ |
|
Pub |
T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T051 |
Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T052 |
Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T053 |
Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T061 |
Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T063 |
Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T071 |
Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 |
US Biomax |
|
88€ |
|
Pub |
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 |
US Biomax |
|
88€ |
|
Pub |
T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T093 |
Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T121 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T123 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T141 |
Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T143 |
Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T151 |
Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T153 |
Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T163 |
Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T172 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 |
US Biomax |
|
88€ |
|
Pub |
T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T193 |
Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T211 |
Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T212 |
Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T221 |
Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T223 |
Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T231 |
Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T261 |
Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T273 |
Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T421 |
Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T461 |
Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199 |
UR1001 |
Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores |
US Biomax |
|
199€ |
|
Pub |
UT1002 Endometrium cancer tissue array for antibody screening, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
UT1002 |
Endometrium cancer tissue array for antibody screening, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed US Biomax 105 |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456 |
AD2081 |
Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores |
US Biomax |
|
278€ |
|
Pub |
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores |
US Biomax |
|
397€ |
|
Pub |
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231 |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b |
US Biomax |
|
231€ |
|
Pub |
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores US Biomax 558 |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores |
US Biomax |
|
558€ |
|
Pub |
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 |
US Biomax |
|
266€ |
|
Pub |
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 |
US Biomax |
|
266€ |
|
Pub |
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a US Biomax 88 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a |
US Biomax |
|
88€ |
|
Pub |
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores US Biomax 112 |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores |
US Biomax |
|
112€ |
|
Pub |
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20818 |
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20819 |
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20820 |
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a |
US Biomax |
|
456€ |
|
Pub |
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2089 |
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88 |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 |
US Biomax |
|
88€ |
|
Pub |
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 |
US Biomax |
|
231€ |
|
Pub |
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 |
US Biomax |
|
456€ |
|
Pub |
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc |
US Biomax |
|
429€ |
|
Pub |
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
CO1922 |
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2086 |
Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 |
US Biomax |
|
189€ |
|
Pub |
CR806 Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
CR806 |
Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
ENS2081 |
Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 US Biomax 266 |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 |
US Biomax |
|
266€ |
|
Pub |
FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626 |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160 |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 |
US Biomax |
|
160€ |
|
Pub |
KD808 Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456 |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2087 |
Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225 |
LC487 |
Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231 |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 |
US Biomax |
|
231€ |
|
Pub |
LV8012 Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 |
MC2082 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 |
MC485 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
MC542 Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 US Biomax 160 |
MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 |
US Biomax |
|
160€ |
|
Pub |
MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0 |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 |
US Biomax |
|
0€ |
|
Pub |
ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 US Biomax 266 |
ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 |
US Biomax |
|
266€ |
|
Pub |
NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266 |
NH1001 |
Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20811 Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20811 |
Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20812 Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20812 |
Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20813 Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20813 |
Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20814 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 US Biomax 558 |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 |
US Biomax |
|
558€ |
|
Pub |
OV243 Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
OV243 |
Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456 |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 |
US Biomax |
|
456€ |
|
Pub |
PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266 |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 |
US Biomax |
|
266€ |
|
Pub |
PR8010 Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 US Biomax 266 |
PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 |
US Biomax |
|
266€ |
|
Pub |
PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487 |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir |
US Biomax |
|
487€ |
|
Pub |
PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35 |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed |
US Biomax |
|
742.35€ |
|
Pub |
SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266 |
SO1001 |
Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266 |
SP1001 |
Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266 |
ST1001 |
Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
T023 Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T023 |
Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T072 |
Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 |
US Biomax |
|
88€ |
|
Pub |
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 |
US Biomax |
|
88€ |
|
Pub |
T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T271 |
Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T301 |
Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T321 |
Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 US Biomax 88 |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 |
US Biomax |
|
88€ |
|
Pub |
UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266 |
UV1001 |
Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores US Biomax 485 |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores |
US Biomax |
|
485€ |
|
Pub |
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 |
US Biomax |
|
336€ |
|
Pub |
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 |
US Biomax |
|
278€ |
|
Pub |
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores |
US Biomax |
|
278€ |
|
Pub |
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 US Biomax 266 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 |
US Biomax |
|
266€ |
|
Pub |
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266 |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 |
US Biomax |
|
266€ |
|
Pub |
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 US Biomax 160 |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 |
US Biomax |
|
160€ |
|
Pub |
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105 |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores US Biomax 88 |
BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores |
US Biomax |
|
88€ |
|
Pub |
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 US Biomax 99 |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 |
US Biomax |
|
99€ |
|
Pub |
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 US Biomax 99 |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 |
US Biomax |
|
99€ |
|
Pub |
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide US Biomax 189 |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide |
US Biomax |
|
189€ |
|
Pub |
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231 |
BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages |
US Biomax |
|
231€ |
|
Pub |
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 |
US Biomax |
|
231€ |
|
Pub |
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores US Biomax 231 |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 US Biomax 266 |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 |
US Biomax |
|
266€ |
|
Pub |
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 |
US Biomax |
|
456€ |
|
Pub |
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742 |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed |
US Biomax |
|
742€ |
|
Pub |
CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores US Biomax 266 |
CLC601 |
Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores |
US Biomax |
|
266€ |
|
Pub |
CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
CO2161 |
Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
CO244 |
Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 |
US Biomax |
|
266€ |
|
Pub |
CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2087 |
Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2089 |
Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide US Biomax 160 |
CR243 |
Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide |
US Biomax |
|
160€ |
|
Pub |
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores US Biomax 314 |
EM1021 |
Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores |
US Biomax |
|
314€ |
|
Pub |
ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
ES243 |
Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 189 |
ES483 |
Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781 |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 |
US Biomax |
|
781€ |
|
Pub |
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 |
US Biomax |
|
336€ |
|
Pub |
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 |
US Biomax |
|
277€ |
|
Pub |
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296 |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
331€ |
|
Pub |
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858 |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258 |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266 |
HE1001 |
Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
HN803 |
Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 US Biomax 321 |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 |
US Biomax |
|
321€ |
|
Pub |
KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20810 |
Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20812 |
Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2089 |
Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
KD243 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD484 |
Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD485 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LC1006 Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 US Biomax 231 |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 |
US Biomax |
|
231€ |
|
Pub |
LC1922 Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores US Biomax 456 |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20813 |
Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20814 |
Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20815 |
Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LC2161 |
Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LC243 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
LC484 |
Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
LC485 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 188 |
LC486 |
Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
188€ |
|
Pub |
LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320 |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267 |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20810 |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV2089 |
Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231 |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 |
LV6161 |
High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185 |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 |
MC2501 |
Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores |
US Biomax |
|
516€ |
|
Pub |
MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 278 |
MC8010 |
Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 US Biomax 314 |
ME1004 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 |
US Biomax |
|
314€ |
|
Pub |
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 |
US Biomax |
|
266€ |
|
Pub |
NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296 |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267 |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |